INTRODUCTION
Nodular regenerative hyperplasia (NRH) is an uncommon liver condition characterized by diffuse transformation of the hepatic parenchyma into regenerative nodules without fibrosis. Nodules vary in size but are usually small. 1 This disease was initially described as "miliary hepatocellular adenomatosis" or "non-cirrhotic nodulation" before first being termed as NRH by Steiner in 1959. 2 NRH can be diagnosed when nodulations evenly distributed across the whole liver are observed on an image study and no histological fibrosis between nodules in a patient with evidence of portal hypertension. NRH leads to non-cirrhotic portal hypertension, the complications of which are the cause of the main symptoms of NRH. The disease progression is slow in most cases but may be accelerated due to other unexpected reasons. 3 The frequency of diagnosis of NRH has increased rapidly in recent years, amounting to hundreds of cases worldwide in the last decade; however, not a single new case has been reported in Korea during the same period of time.
Here, we report on our experience with a patient of NRH combined with toxic hepatitis, together with a literature review.
CASE REPORT
A 54-year-old woman with no specific medical history visited our hepatology clinic for jaundice and lower limb edema that had lasted for about 10 days. She had been suffering from nausea and abdominal discomfort for almost a month, for which she had taken herbal medicines for one week. anti-HEV were all negative. Autoimmune markers, including anti-nuclear, anti-smooth muscle, anti-mitochondrial, antidsDNA, and anti-cardiolipin antibodies, were also negative.
Ceruloplasmin, serum copper, and serum iron were all within
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Abdominal ultrasonography at the primary care showed coarse echotexture of the liver parenchyma; however, no nodules were observed. Abdominal CT scan at our hospital showed high-attenuation nodules distributed across the liver on the precontrast phase and decreased enhancement compared to the adjacent liver parenchyma (Fig. 1A) . A moderate amount of ascites was observed but portal vein thrombosis was not present (Fig. 1B) . Liver MRI demonstrated numerous large nodular lesions in both T2 low signal and T1 high signal images (Fig. 2) . Repeat esophagogastroduodenoscopy showed a healing duodenal ulcer but no esophageal or gastric varix. Colonoscopy findings were unremarkable.
Liver biopsy was performed and microscopic examination revealed that the lesion was composed of hepatocytes arranged in two-to three cell-thick plates and diffuse small cell or large cell changes were seen (Fig. 3A) . Masson trichrome stain protocol for collagen fibers showed no fibrosis and there was no evidence of dysplastic or carcinomatous changes of hepatocytes (Fig. 3B) . Conclusively, the investigations showed marked regenerative hepatocytic changes without fibrosis, which conformed to the definition of NRH.
Based on the above mentioned findings, the patient was finally diagnosed with NRH associated with toxic hepatitis. numerable nodular lesions in the liver and increase of numbers compared to the previous MRI. This finding suggested some progression of NRH in the liver (Fig. 4) . However the laboratory findings were still within normal limit. She has been on regular follow-up on an outpatient basis.
DISCUSSION
NRH is a rare disease; the current knowledge regarding NRH has been obtained mainly from case reports and only a few large studies. NRH is underdiagnosed and underreported because of the difficulty of the diagnostic approach.
Only a few cases of NRH have been reported in Korea. [4] [5] [6] An autopsy study of 2,500 patients found the presence of NRH in 64 patients, 2.6% of the overall incidence. 1 Many of these patients had accompanying systemic disorders, and the incidence of NRH among patients aged 80 years and older was seven times higher than that among patients aged 60 years and younger, thereby suggesting that older patients with an associated systemic disease are more susceptible to NRH. 1 The pathogenesis of NRH is not yet well established, however, adaptive hyperproliferative response of hepatocytes to alteration in portal hepatic venous perfusion is assumed to be the main mechanism. 7 NRH is also highly associated with underlying diseases, including autoimmune, inflammatory, and neoplastic disorders. 8 In addition, NRH has often been reported in patients after chemotherapy with certain drugs 9 and use of immunosuppressant such as thiopurine, which may cause damage to hepatic venous endothelial cells.
10,11
However, our patient had no medical history or disorder that might be considered as a cause of NRH.
NRH is not a common disease; however, it should be sus- and are known to show only non-specific, diffuse liver disease or several millimeters of tiny regenerative nodules evenly distributed across the liver. 13, 14 However, reports indicate that, although rare, macronodules may be detected by imaging, 15, 16 which was applicable in our case. In the end, histopathologic confirmation by liver biopsy is the gold standard for a definite diagnosis.
진선미 등. 독성 간염을 동반한 간의 결절성 재생증식
The Korean Journal of Gastroenterology
In management of patients with NRH, the priority is treatment of causal factors and control of symptoms arising from portal hypertension. Ascites and esophageal varix may be managed by conventional standard treatments such as diuretics, endoscopic variceal ligation, and portosystemic shunt.
Liver transplantation is rarely attempted.
Disease progression is slow in most cases. The expected prognosis is presumably better than in cirrhosis or other chronic liver diseases; however, long-term prognosis is still unknown. NRH was associated with hepatocellular carcinoma in several reported cases; however, there is no evidence suggesting that these NRH cases were pre-malignant lesions. 3, 17 Further studies are needed in order to obtain long-term data on the natural history of NRH and to determine the etiology of NRH, particularly the molecular pathogenesis associated with portal vasculopathy and tumorigenesis.
In conclusion, NRH is an uncommon liver condition, which probably has a benign progressive course. We presented a patient who showed a macronodular hepatic lesion on radiologic finding and was finally diagnosed with NRH based on histology results. We believe that the herbal medicine that the patient had been taking before the symptoms appeared, might have led to the development of toxic hepatitis in addition to the underlying NRH.
